The North American Menopause Society Statement on Continuing Use of Systemic Hormone Therapy After Age 65

Menopause. 2015 Jul;22(7):693. doi: 10.1097/GME.0000000000000492.
No abstract available

Publication types

  • Practice Guideline

MeSH terms

  • Age Factors
  • Aged
  • Aged, 80 and over
  • Contraindications
  • Estrogen Replacement Therapy*
  • Female
  • Humans
  • Menopause / drug effects*
  • Quality of Life
  • Risk Assessment
  • United States